DK171726B1 - Monoethanolaminsaltet af N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid på særlig krystallinsk form - Google Patents

Monoethanolaminsaltet af N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid på særlig krystallinsk form Download PDF

Info

Publication number
DK171726B1
DK171726B1 DK527585A DK527585A DK171726B1 DK 171726 B1 DK171726 B1 DK 171726B1 DK 527585 A DK527585 A DK 527585A DK 527585 A DK527585 A DK 527585A DK 171726 B1 DK171726 B1 DK 171726B1
Authority
DK
Denmark
Prior art keywords
polymorph
benzothiazine
hydroxy
carboxamide
pyridyl
Prior art date
Application number
DK527585A
Other languages
Danish (da)
English (en)
Other versions
DK527585D0 (da
DK527585A (da
Inventor
Robert Lee Robertson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK527585D0 publication Critical patent/DK527585D0/da
Publication of DK527585A publication Critical patent/DK527585A/da
Application granted granted Critical
Publication of DK171726B1 publication Critical patent/DK171726B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L57/00—Protection of pipes or objects of similar shape against external or internal damage or wear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
DK527585A 1984-11-16 1985-11-15 Monoethanolaminsaltet af N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid på særlig krystallinsk form DK171726B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67202884 1984-11-16
US06/672,028 US4582831A (en) 1984-11-16 1984-11-16 Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor

Publications (3)

Publication Number Publication Date
DK527585D0 DK527585D0 (da) 1985-11-15
DK527585A DK527585A (da) 1986-05-17
DK171726B1 true DK171726B1 (da) 1997-04-14

Family

ID=24696846

Family Applications (1)

Application Number Title Priority Date Filing Date
DK527585A DK171726B1 (da) 1984-11-16 1985-11-15 Monoethanolaminsaltet af N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid på særlig krystallinsk form

Country Status (28)

Country Link
US (1) US4582831A (sv)
EP (1) EP0182572B1 (sv)
JP (1) JPS61122284A (sv)
KR (1) KR870000291B1 (sv)
CN (1) CN1004001B (sv)
AT (1) ATE50257T1 (sv)
AU (1) AU556378B2 (sv)
CA (1) CA1209572A (sv)
DD (1) DD242405A5 (sv)
DE (1) DE3575925D1 (sv)
DK (1) DK171726B1 (sv)
EG (1) EG17621A (sv)
ES (1) ES8701712A1 (sv)
FI (1) FI82045C (sv)
GR (1) GR852772B (sv)
HU (1) HU197899B (sv)
IE (1) IE58288B1 (sv)
IL (1) IL77051A (sv)
IN (1) IN164207B (sv)
MY (1) MY101984A (sv)
NO (1) NO854574L (sv)
NZ (1) NZ214201A (sv)
PH (1) PH21322A (sv)
PL (1) PL149466B1 (sv)
PT (1) PT81490B (sv)
SU (1) SU1491339A3 (sv)
YU (1) YU44019B (sv)
ZA (1) ZA858773B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
MY142390A (en) 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
ECSP077628A (es) * 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
ES2782898T3 (es) 2009-05-29 2020-09-16 Novartis Ag Métodos de administración de compuestos agonistas de la trombopoyetina
CN102470136B (zh) * 2009-07-29 2013-12-25 内尔维阿诺医学科学有限公司 Plk 抑制剂的盐类
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
IN160683B (sv) * 1981-06-01 1987-07-25 Pfizer
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice

Also Published As

Publication number Publication date
EG17621A (en) 1991-08-30
YU178585A (en) 1987-12-31
MY101984A (en) 1992-02-29
PT81490B (pt) 1988-03-03
ZA858773B (en) 1987-06-24
YU44019B (en) 1990-02-28
IL77051A0 (en) 1986-04-29
PL149466B1 (en) 1990-02-28
PT81490A (en) 1985-12-01
DE3575925D1 (de) 1990-03-15
IE58288B1 (en) 1993-08-25
PL256259A1 (en) 1986-10-07
FI854512A (fi) 1986-05-17
HUT40116A (en) 1986-11-28
ES8701712A1 (es) 1986-12-01
ES548878A0 (es) 1986-12-01
JPS61122284A (ja) 1986-06-10
US4582831A (en) 1986-04-15
KR860004038A (ko) 1986-06-16
SU1491339A3 (ru) 1989-06-30
FI82045C (sv) 1991-01-10
EP0182572B1 (en) 1990-02-07
IE852852L (en) 1986-05-16
CN1004001B (zh) 1989-04-26
NZ214201A (en) 1988-07-28
ATE50257T1 (de) 1990-02-15
GR852772B (sv) 1986-03-14
EP0182572A1 (en) 1986-05-28
CN85108245A (zh) 1986-09-03
JPH0425957B2 (sv) 1992-05-06
FI854512A0 (fi) 1985-11-15
AU556378B2 (en) 1986-10-30
DK527585D0 (da) 1985-11-15
DD242405A5 (de) 1987-01-28
IN164207B (sv) 1989-01-28
NO854574L (no) 1986-05-20
IL77051A (en) 1989-03-31
DK527585A (da) 1986-05-17
FI82045B (fi) 1990-09-28
PH21322A (en) 1987-09-28
HU197899B (en) 1989-06-28
CA1209572A (en) 1986-08-12
AU4995085A (en) 1986-05-22
KR870000291B1 (ko) 1987-02-25

Similar Documents

Publication Publication Date Title
KR850001883B1 (ko) 결정성 벤조티아진 디옥시드 염류의 제조방법
CA1294967C (fr) Derives du 1h, 3h-pyrrolo [1,2-c] thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
DK171726B1 (da) Monoethanolaminsaltet af N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid på særlig krystallinsk form
EP0057059A1 (en) Benzothiazine dioxide anti-inflammatory agents, processes for their preparation, and pharmaceutical compositions containing them
US3362962A (en) Certain benzothiazepine derivatives
CA1084918A (en) New, in 11-position substituted 5,11-dihydro-6h- pyrido 2,3-b - 1,4 benzodiazepine-6-ones, processes for their preparation and pharmaceutical compositions containing such compounds
IE48740B1 (en) N-(2-thiazolyl)amides and their use as anti-inflammatory and immunoregulatory agents
CA2091688A1 (en) Antiproliferative substituted naphthalene compounds
Corrie et al. Synthesis of a cephalosporin analogue
EP0100815B1 (en) N-(1,3-dithiolan-2-ylidene)anilines and their use as anti-inflammatory and anti-asthmatic agents
NO850725L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksikam-derivater.
CS228930B2 (cs) Způsob výroby krystalických, nehygroskopických, ve vodě rozpustných solí N- (2-pyridyl) -2-methyl-4-hydroxy-2H-l,2-benzothiazin-3- -karboxamid-l,l-dioxidu
US4220650A (en) Organic diamine therapeutic compositions and methods
US3646038A (en) 1-(n-methylpiperazineacetyl)aminofluorene
US4256753A (en) 4-(2-Pyridylamino)phenylacetic acid derivatives
JPS6289686A (ja) ４，９−ジヒドロ−１０Ｈ−ピリド〔３，２−ｂ〕−チエノ〔３，２−ｅ〕〔１，４〕ジアゼピノンおよび４，９−ジヒドロ−１０Ｈ−ピリド〔３，２−ｂ〕チエノ〔３，４−ｅ〕〔１，４〕ジアゼピノンのアミノアシル誘導体、これらの製造およびこれらを含む薬剤組成物
Walker 129. Some N4-diethylaminoalkyl-N1-dialkylsulphanilamides and related compounds
SE463716B (sv) 2-halonicergolinderivat, foerfarande foer framstaellning av detta och en farmaceutisk beredning
US4333932A (en) Organic diamine therapeutic compositions and methods
NO148108B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolin-acetamid-derivater
JPS61109770A (ja) ２位置にα‐ヒドロキシル鎖が置換した４‐ヒドロキシ‐３‐キノリンカルボン酸より誘導される新エステル、その製造、薬剤としての使用及びそれを含む組成物
Martinez-Merino et al. NEW 5-SUBSTITUTED DERIVATIVES OF ETHYL 2, 3-DIHYDRO
JPS63126884A (ja) オキサゾロチエノピリミジン誘導体
DE3635696A1 (de) Benzo-1,3,2-dithiazol-1,1-dioxide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IL32203A (en) 5-imino-1,2,4-triazine derivatives,their preparatibenzoxazol-2-yl-n-methyl-n-naphth-1-yl dithiocarbamate,its production and pharmaceutical compositionon and use as herbicides s containing it

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK